BioSpace News Archive

Today, RADIUS, a leading innovator in specialty toothbrushes, toothpastes and personal care products, announced the company’s bold new sustainability mission.

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.

The Patented Medicine Prices Review Board (PMPRB) released its new draft Guidelines today and launched a 60-day consultation period with stakeholders and interested members of the public.

Blue Cross Blue Shield of Massachusetts announced the five nonprofit recipients of its new Healthy Living Accelerator Grants. The Healthy Living Accelerator Grants fund unique and innovative programs and initiatives that influence behavior change and advance the health of Massachusetts residents by addressing the inter-connectedness of healthy eating, active lifestyles, and positive environments.

Rightway Healthcare, a New York-based patient navigation and healthcare advocacy platform for employers and their employees, today announced it secured $20 million in a Series B funding round led by Thrive Capital.

Ultra-High Purity, Pharmaceutical-Grade CBD and Other Derivatives Are Available for Clinical Study and Broad Range of Pharmaceutical and Consumer Products

Gene By Gene is playing a crucial role in helping law enforcement solve cold cases.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, is scheduled to present at the following investor conferences:

XCOPRI is approved for the treatment of partial-onset seizures in adult patients

New standard for medication adherence and engagement emerges with growing number of patients using spencer® to manage health at home